India’s Drug Regulator Wants the World to Rethink Its Assumptions
From stricter standards to cutting-edge therapies, DCGI Dr. Rajeev Singh Raghuvanshi outlines how India is repositioning itself as a global pharmaceutical force.
By continuing you agree to our Privacy Policy & Terms & Conditions
Stay Informed. Sign Up Now!
By continuing you agree to our Privacy Policy & Terms & Conditions
By continuing you agree to our Privacy Policy & Terms & Conditions
Boost your brand’s visibility and establish industry thought leadership
Connect with key stakeholders and drive growth
Connect with industry influencers and CXOs by presenting your products and services
